Yet, only Saxenda and Wegovy have approval for obesity treatment, even though Ozempic and other GLP-1 RAs are frequently prescribed off-label for weight loss
We additionally accounted for sex, race, ethnicity, BMI prior to starting the GLP-1, change in BMI upon starting the GLP-1 as well as throughout their usage, use of osteoporosis medications, steroid use, smoking history, and comorbidities including hyperparathyroidism, chronic falls, cancer, CKD, malabsorption, IBD, and eating disorders in our analysis
They are usually injectable medications, with a liquid medication injected into the fatty tissue just under your skin
Importantly, Zepbound carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)